• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.

作者信息

Castaño Adam, Bokhari Sabahat, Maurer Mathew S

机构信息

Center for Advanced Cardiac Care, Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Center for Advanced Cardiac Care, Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, NY, USA

出版信息

Eur Heart J. 2015 Oct 7;36(38):2595-7. doi: 10.1093/eurheartj/ehv328. Epub 2015 Jul 28.

DOI:10.1093/eurheartj/ehv328
PMID:26224073
Abstract
摘要

相似文献

1
Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.揭示野生型转甲状腺素蛋白心脏淀粉样变性是射血分数保留的心力衰竭的一个重要且可能可改变的病因。
Eur Heart J. 2015 Oct 7;36(38):2595-7. doi: 10.1093/eurheartj/ehv328. Epub 2015 Jul 28.
2
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.野生型转甲状腺素蛋白淀粉样变性导致射血分数保留的心力衰竭。
Eur Heart J. 2015 Oct 7;36(38):2585-94. doi: 10.1093/eurheartj/ehv338. Epub 2015 Jul 28.
3
Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis.M 型超声心动图心肌收缩分数优于射血分数预测转甲状腺素蛋白淀粉样变性患者的死亡率。
J Card Fail. 2018 Aug;24(8):504-511. doi: 10.1016/j.cardfail.2018.07.001. Epub 2018 Aug 17.
4
Acute cardiac failure secondary to senile systemic amyloidosis.老年性系统性淀粉样变性继发急性心力衰竭。
Age Ageing. 2016 Nov;45(6):908-909. doi: 10.1093/ageing/afw073. Epub 2016 Apr 21.
5
Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.心力衰竭伴射血分数保留患者中应用亲骨性放射性示踪剂对转甲状腺素蛋白心脏淀粉样变进行临床表型分析。
Curr Cardiol Rep. 2018 Mar 8;20(4):23. doi: 10.1007/s11886-018-0970-2.
6
Prevalence of wild-type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo-VIP-HF study.射血分数保留和轻度降低的前瞻性心力衰竭队列中野生型转甲状腺素蛋白淀粉样变性的患病率：淀粉样变-VIP-HF研究结果
Eur J Heart Fail. 2024 Mar;26(3):695-698. doi: 10.1002/ejhf.3186. Epub 2024 Mar 4.
7
Wild-Type Transthyretin Amyloid Cardiomyopathy: A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications.野生型转甲状腺素蛋白淀粉样心肌病：射血分数保留的心力衰竭的一个被忽视的病因及不断演变的治疗意义。
Circulation. 2016 Jan 19;133(3):245-7. doi: 10.1161/CIRCULATIONAHA.115.020351. Epub 2015 Dec 11.
8
[Problems of diagnostics and treatment of transtiretinum amyloidosis with destruction of the heart in the elderly: Clinical experience.].[老年转甲状腺素蛋白淀粉样变性伴心脏损害的诊断与治疗问题：临床经验。]
Adv Gerontol. 2019;32(1-2):137-144.
9
From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.从肥厚型心肌病到转甲状腺素蛋白淀粉样变性：一例罕见病例及具有挑战性的诊断
Pol Arch Intern Med. 2020 Feb 27;130(2):153-154. doi: 10.20452/pamw.15140. Epub 2020 Jan 14.
10
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.在日常实践中筛查转甲状腺素蛋白淀粉样心肌病。
JACC Heart Fail. 2019 Aug;7(8):709-716. doi: 10.1016/j.jchf.2019.04.010. Epub 2019 Jul 10.

引用本文的文献

1
Wild-type Cardiac Amyloidosis due to Transthyretin Protein - A Review.由转甲状腺素蛋白引起的野生型心脏淀粉样变——综述
J Community Hosp Intern Med Perspect. 2025 May 5;15(3):46-53. doi: 10.55729/2000-9666.1485. eCollection 2025.
2
Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan.日本射血分数保留的心力衰竭患者中甲状腺转运蛋白淀粉样变性的患病率。
ESC Heart Fail. 2023 Jun;10(3):1896-1906. doi: 10.1002/ehf2.14364. Epub 2023 Mar 27.
3
RV-PA uncoupling is associated with increased mortality in transthyretin amyloid cardiomyopathy treated with tafamidis.
在接受塔非酰胺治疗的转甲状腺素蛋白淀粉样心肌病中，右心室-肺动脉解偶联与死亡率增加相关。
Clin Res Cardiol. 2024 Nov 20. doi: 10.1007/s00392-024-02576-2.
4
Mexican position paper for the diagnosis and treatment of cardiac amyloidosis.墨西哥心脏淀粉样变性诊断和治疗立场文件
Arch Cardiol Mex. 2024;94(Supl 3):1-33. doi: 10.24875/ACM.M24000097.
5
Amyloid Burden Correlates with Electrocardiographic Findings in Patients with Cardiac Amyloidosis-Insights from Histology and Cardiac Magnetic Resonance Imaging.淀粉样蛋白负荷与心脏淀粉样变性患者的心电图表现相关——来自组织学和心脏磁共振成像的见解
J Clin Med. 2024 Jan 9;13(2):368. doi: 10.3390/jcm13020368.
6
Cardiac Amyloidosis and Valvular Heart Disease.心脏淀粉样变性与心脏瓣膜病
J Clin Med. 2023 Dec 30;13(1):221. doi: 10.3390/jcm13010221.
7
Prognosis prediction in cardiac amyloidosis by cardiac magnetic resonance imaging: a systematic review with meta-analysis.心脏磁共振成像对心脏淀粉样变性的预后预测：一项荟萃分析的系统评价
Eur Heart J Open. 2023 Sep 22;3(5):oead092. doi: 10.1093/ehjopen/oead092. eCollection 2023 Sep.
8
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials.治疗转甲状腺素蛋白淀粉样变心肌病：临床试验的经验教训
Front Cardiovasc Med. 2023 May 23;10:1154594. doi: 10.3389/fcvm.2023.1154594. eCollection 2023.
9
The utility of positron emission tomography in cardiac amyloidosis.正电子发射断层扫描在心脏淀粉样变性中的应用。
Heart Fail Rev. 2022 Sep;27(5):1531-1541. doi: 10.1007/s10741-021-10183-w. Epub 2021 Nov 7.
10
Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases.甲状腺素运载蛋白：从结构稳定性到骨关节炎和心血管疾病。
Cells. 2021 Jul 13;10(7):1768. doi: 10.3390/cells10071768.